XENOTHERA’s €20 Million Equity Funding Round

Linklaters advised the EIC Fund (European Innovation Council Fund) on the deal.Created in 2014, XENOTHERA is a French biotech developing a technological platform of glyco-humanized polyclonal…

This content is for Standard 1 Year members only.
Login Join Now
Federica Tiefenthaler

Author: Federica Tiefenthaler

This content is for Standard 1 Year members only.
Login Join Now